KRISTY BOAGNI: Open Payments
NPI 1881253219 · OPELOUSAS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,498 in 92 payments from 8 companies in 2025. Trend: 2023 $722 · 2024 $1,382 · 2025 $1,498
Food & beverage: $1,498
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $441 |
| Janssen Biotech, Inc. | 21 | $418 |
| Ardelyx, Inc. | 21 | $285 |
| Phathom Pharmaceuticals, Inc. | 9 | $123 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $80 |
| PFIZER INC. | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Novo Nordisk Inc | 1 | $23 |
Products named: TREMFYA, IBSRELA, RINVOQ, SKYRIZI, VOQUEZNA, ENTYVIO, LINZESS, RELISTOR.
Industry payments across LA — which companies pay providers there.
